Cetuximab is a chimeric (mouse/human) monoclonal antibody that targets the epidermal growth factor receptor (EGFR), which is often overexpressed in various human cancers. It is primarily used in the treatment of metastatic colorectal cancer and squamous cell carcinoma of the head and neck.
